Since CTTS responses are triggered by inflammatory stimuli and CTSS deficiency can attenuate MHC class II presentation, many investigators have focused on CTSS as a target in immunological disorders, such as lupus, rheumatoid arthritis, Sjögren’s syndrome and encephalomyelitis. The gene discussed is CTSS; the disease is encephalomyelitis.